Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

IMPACT OF PNEUMOCYSTIS-CARINII AND CYTOMEGALOVIRUS ON THE COURSE AND OUTCOME OF ATYPICAL PNEUMONIA IN ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE JOURNAL OF INFECTIOUS DISEASES Bozzette, S. A., ARCIA, J., BARTOK, A. E., McGlynn, L. M., McCutchan, J. A., Richman, D. D., Spector, S. A. 1992; 165 (1): 93-98

Abstract

Patients undergoing bronchoscopy for possible pneumocystis pneumonia were studied retrospectively to characterize the impact of common viral pathogens on the course of advanced human immunodeficiency virus (HIV) disease and atypical pneumonia. In 327 episodes, Pneumocystis carinii was found in 220 (67%), cytomegalovirus (CMV) in 145 (44%), and herpes simplex virus in 16 (5%). Early deterioration in oxygenation and use of intensive care was less common in CMV-positive patients. Neither CMV nor P. carinii was a predictor of mortality in multivariate analyses. CMV was not associated with an increased prevalence of later CMV disease. Isolation of CMV from the bronchoalveolar lavage fluid of these patients was not an indication for antiviral therapy. Pulmonary shedding of CMV may be associated with a decreased inflammatory response to P. carinii. The outcome of HIV-associated atypical pneumonia where no clear pulmonary pathogen is found on routine evaluation was no better than that of treated P. carinii pneumonia.

View details for Web of Science ID A1992GW58200012

View details for PubMedID 1309375